Anan Jongkaewwattana, Ph.D is currently the Director of Virology and Antibody Technology Research Unit at the National Center for Genetic Engineering and Biotechnology (BIOTEC). He obtained the royal Thai scholarship sponsored by the Ministry of Science and Technology. After his undergraduate study in Cell and Molecular Biology at the University of Michigan at Ann Arbor in 1998, he did his graduate work on the role of p53 tumor suppressor protein in HIV and SIV pathogenesis at the University of Alabama Medical School in Birmingham, USA. Dr. Jongkaewwattana's postdoctoral training, with Drs. Erich Hoffmann and Robert G Webster at St. Jude Children’s research hospital in Memphis, Tennessee, dealt with the development of avian influenza A virus vaccines using reverse genetics technology. He joined BIOTEC, as a full-time researcher, in 2005. His research strengths lie in molecular virology and modern vaccinology, and Dr. Jongkaewwattana is among the leading scientists in swine coronavirus research. Recently, together with other colleagues at BIOTEC, his team was internationally recognized as the first group that developed the reverse genetics system of porcine epidemic diarrhea virus (PEDV). Dr. Jongkaewwattana is currently the principal investigator of several grants including NSTDA Giga Impact Initiative on PEDV vaccine development and the Thailand-UK Newton Fund on novel Newcastle Disease vaccine development.